Picture of Hypertension: New Frontiers—A Textbook of Cardiology

Hypertension: New Frontiers—A Textbook of Cardiology

Editor-in-Chief: HK Chopra, Navin C Nanda, Jagat Narula, GS Wander, CN Manjunath, Praveen Chandra
$140.00

Salient Features

Hypertension: New Frontiers—A Textbook of Cardiology, is the first publication of its kind in the form of a Textbook of Cardiology from India to the world. Approx. 300 contributors from India and abroad have contributed their prestigious chapters in this book, focus on every aspect of cardiovascular imaging and intervention, thereby enhancing knowledge and have tremendous innovative and research potential of understanding advances and innovations in hypertension for the undergraduates, postgraduates, practicing cardiologists, endocrinologists, nephrologists, neurologists, critical care specialists, pulmonologists, pediatricians, pediatric surgeons, physicians, cardiovascular surgeons, imaging experts, nutritionists, etc. Various sections of the book including Clinical, Diagnostic Methodology, Echocardiography, Hypertension to Heart Failure, Hypertension to Stroke, Hypertension and Aorta, Hypertension and Renovascular Diseases, Hypertension and Intervention, Hypertension and Carotid Artery Disease, Hypertension and Peripheral Vascular Disease, Clinical Management Strategies, Pediatric Cardiology, Metabolic Syndrome and Hypertension, Nutrition and Hypertension, Cardio-oncology and Hypertension, Systematic Inflammatory Release Syndrome with Resistant Hypertension, ECMO and Hypertension, Rehabilitation, and Future Directions.


Table of Contents

Buy as you go

Buy by the chapter and never pay more than the price of the full book.
Chapter 1: Current Challenges and Future Directions in the Clinical Management of Hypertension
Chapter 2: Controversies to Consensus in Hypertension Classification and their Impact
Chapter 3: Risk Factors Responsible for Hypertension
Chapter 4: Pathophysiology of Hypertension
Chapter 5: OSA and Hypertension:Present Status and Future Directions
Chapter 6: Obstructive Sleep Apnea and Systemic Hypertension
Chapter 7: Microalbuminuria, Hypertension and Diabetes Mellitus: A Triple Jeopardy
Chapter 8: Hypertension in Elderly Diabetics:Management Strategies
Chapter 9: Hypertension in Young:Management Strategies
Chapter 10: Hypertension in Women:Is it different?
Chapter 11: Hypertension in Elderly in what Way Management is Different
Chapter 12: Stress, Mental Pollution and Hypertension
Chapter 13: Sex and Hypertension:Myth and Facts
Chapter 14: Exercise and Hypertension
Chapter 15: COVID-19 and Systemic Hypertension
Chapter 16: The Role of Autonomic Nervous System in Hypertension
Chapter 17: Vascular Disease and Hypertension
Chapter 18: Air Pollution and Hypertension
Chapter 19: Eye and Hypertension:Changing Perspectives
Chapter 20: Noise Pollution and Hypertension
Chapter 21: Does Hypertension and Its Pharmacotherapy Affect the Quality of Sexual Function?
Chapter 22: Reduction of BP Targets to Reduce CVD Events: Status 2020 and Beyond
Chapter 23: Salt Sensitive Hypertension:Emerging Insights in an Old Entity
Chapter 24: White Coat Hypertension:Clinical Outcome
Chapter 25: Critical Appraisal of Essential Hypertension in Young Adults
Chapter 26: Hypertension and Endothelial Dysfunction
Chapter 27: Hypertension and Aortoarteritis
Chapter 28: Hypertension and Left Ventricular Hypertrophy: Clinical Implications
Chapter 29: Hypertension and CKD:A Double Jeopardy
Chapter 30: Hypertension and Conn's Syndrome:Management Strategies
Chapter 31: Renin–Angiotensin–Aldosterone System 2020
Chapter 32: Hypertension and Sildenafil
Chapter 33: Hypertension, Seasonal, Diurnal BP Variability and CVD Risk
Chapter 34: The Management of Hypertension during the Perioperative Period
Chapter 35: Hypertension Preventive Strategies and Campaign in India
Chapter 36: Hypertension with Multiple Comorbidities
Chapter 37: Aortic Dissection in Hypertension:Management Strategies
Chapter 38: Long-term Cardiovascular Sequelae of Uncontrolled Hypertension and their Surgical Management
Chapter 39: Hypertension with Arterial Dissections: A Jeopardy
Chapter 40: Hypertension with Renal Artery Stenosis: Management Strategies
Chapter 41: Orthostatic Hypotension in Hypertensives Patients: Management Strategies
Chapter 42: Importance of HBPM in Hypertension
Chapter 43: Power and Promise of Home BP Monitoring
Chapter 44: Power and Promise of ABPM in Hypertension Evaluation
Chapter 45: Nondipping, Early Morning Surge in Hypertension in Isolated Systolic Hypertension in Elderly
Chapter 46: Diagnostic, Prognostic and Therapeutic Implications of Nocturnal Nondipper, Reverse Dipper and Extreme Dipper in Hypertension Management
Chapter 47: Significance of Central Aortic Blood Pressure Monitoring in Hypertension
Chapter 48: Lab Medicine and Hypertension:Clinical Impact
Chapter 49: Hypertension and CRP Evaluation
Chapter 50: ECG in Hypertensive Heart Disease
Chapter 51: Role of MRI in the Evaluation of Hypertension
Chapter 52: Multimodality Imaging Evaluation of Renovascular Disease in Hypertension
Chapter 53: Artificial Intelligence and Hypertension
Chapter 54: 3D Echo Evaluation in Hypertension
Chapter 55: LA and LV Strain Evaluation in Hypertension
Chapter 56: Echocardiography in Hypertension: Diagnostic, Prognostic, and Therapeutic Implications
Chapter 57: LA Volume/LA Stiffness Index Evaluation by Echocardiography in Hypertension
Chapter 58: Left Atrial Strain in Hypertension
Chapter 59: Advances in LV Strain Evaluation by Echocardiography in Hypertension
Chapter 60: Erectile Dysfunction in Hypertension;Doppler Evaluation and Management Strategies
Chapter 61: Echocardiographic Evaluation of Left Ventricular and Left Atrial Strain in Hypertension: Diagnostic, Prognostic and Therapeutic Implications
Chapter 62: Advances in Echocardiographic Evaluation of Hypertension with Takotsubo Syndrome
Chapter 63: Low Diastolic Blood Pressure in Elderly: Management Strategies
Chapter 64: Role of Echocardiography in Hypertension
Chapter 65: Chlorthalidone: Efficacy and Outcome Evaluation in Hypertension
Chapter 66: Diuretic Effect and Outcome Evaluation by Echocardiographic Variables in Hypertension
Chapter 67: Pharmacological Treatment of Resistant Hypertension: What is New?
Chapter 68: Aortic Stenosis and Hypertension:A Double Jeopardy Echo Evaluation
Chapter 69: Rakesh Sarkar, Kartikeya Bhargava
Chapter 70: Hypertension and Cardiac Arrhythmias
Chapter 71: Cut-offs for Hypertension in India:Implications for 2020 and Beyond
Chapter 72: LVH in Echo: Hypertrophic Response or Hypertrophic Cardiomyopathy?
Chapter 73: Role of Left Ventricular Longitudinal Strain Imaging in Systemic Hypertension
Chapter 74: Hypertensive Emergency and Urgency: Echocardiographic Evaluation
Chapter 75: Transition from Hypertension to Heart Failure: Management Strategies
Chapter 76: Uncontrolled Hypertension to Heart Failure with Preserved Ejection Fraction
Chapter 77: Hypertension to HEpEF:Where are we Today?
Chapter 78: Cardiorenal Syndrome in Hypertension
Chapter 79: Hypertension, Stroke and Heart Failure Connect: Prognosis and Outcome
Chapter 80: Practical Use of ARNI in Hypertension with Heart Failure
Chapter 81: ARNI in Hypertension with NYHA Class II HF: What is the Evidence?
Chapter 82: Indication of ARNI in Hypertension in ICCU
Chapter 83: ARNI in Hypertension with ACS and Heart Failure
Chapter 84: ARNI: Morbidity and Mortality Benefits in Heart Failure with Hypertension
Chapter 85: Diagnostic, Prognostic and Therapeutic Implications of Advance Echocardiography in Hypertension with HFrEF
Chapter 86: Hypertension and Stroke
Chapter 87: Hypertension and Multiple Lacuna Infarcts
Chapter 88: Echocardiographic Evaluation of the Aorta in Hypertension
Chapter 89: Aortic CT Evaluation of Hypertension
Chapter 90: Aortic MR Evaluation in Hypertension
Chapter 91: Ultrasonographic Evaluation of Renovascular Disease in Hypertension
Chapter 92: Magnetic Resonance Imaging Evaluation of Renovascular Disease in Hypertension
Chapter 93: Management of Hypertension in Patients with ACS
Chapter 94: Hypertension in STEMI and Other ACS
Chapter 95: Hypertension in Patients Undergoing Percutaneous Coronary Interventions
Chapter 96: Hypertension and Diabetes:Post-PCI—Management Strategies
Chapter 97: Pre, during and Post-CABG with Hypertension
Chapter 98: Post-ICD with Hypertension
Chapter 99: Interventional Therapies in Resistant Hypertension
Chapter 100: Hypertension Management before, during and after LVAD Implantation
Chapter 101: The Curious Case of Systolic Hypertension
Chapter 102: Current Status of Renal Denervation Therapy
Chapter 103: Post Heart Transplant with Hypertension
Chapter 104: Carotid Artery Disease: Diagnostic, Prognostic and Therapeutic Implications in Hypertension
Chapter 105: Diagnostic, Management, and Prognostic Implications of Peripheral Artery Disease in Hypertension
Chapter 106: Ideal Methods of Blood Pressure Measurements
Chapter 107: Beta-blockers and Hypertension:What is the Effect and Outcome?
Chapter 108: Bisoprolol in Hypertension
Chapter 109: Role of Statins in Hypertension with CVD Comorbidities
Chapter 110: Power and Promise of Telmisartan in Hypertension Management
Chapter 111: Angiotensin Receptor Blockers and Hypertension
Chapter 112: Alpha-blockers and Hypertension
Chapter 113: Alpha-Beta Blockers and Hypertension
Chapter 114: Diuretics in Hypertension: Status 2020
Chapter 115: Diuretics as Antihypertensive in Elderly:Issues and Challenges
Chapter 116: Single Pill Combination Antihypertensive Therapy is the Only Way to Mitigate the Menace of Hypertension
Chapter 117: Chlorthalidone and Hypertension:Choosing the Right Antihypertensive for CV Risk Reduction
Chapter 118: Mineralocorticoid Antagonists in Resistant Hypertension 2020 and Beyond
Chapter 119: Eplerenone: A Novel Mineralocorticoid Receptor Antagonist for Resistant Hypertension
Chapter 120: ARNI and Hypertension:Present Status and Future Directions
Chapter 121: SGLT2 Inhibitors and Hypertension:Present Status and Future Directions
Chapter 122: Combination Therapy in Hypertension:What is the Rationale?
Chapter 123: Hypertensive Crisis:Management Strategies
Chapter 124: NOAC Safety in AF with Hypertension
Chapter 125: Resistant Hypertension—A Global Tsunami: How to Manage?
Chapter 126: Telemedicine and its Role in the Management of Resistant Hypertension
Chapter 127: Hypertension in STEMI:Management Strategies
Chapter 128: Postural Variability of Blood Pressure:Clinical Importance
Chapter 129: Azilsartan: Newer ARB in Difficult to Treat Hypertension
Chapter 130: Management Strategies for Hypertension in Children
Chapter 131: Hypertension and Stroke in Pediatric Population
Chapter 132: Heart Failure in Pediatric Hypertension
Chapter 133: Pediatric Hypertension: An Overview
Chapter 134: Metabolic Syndrome and Hypertension
Chapter 135: Hypothyroid and Hypertension
Chapter 136: Hyperthyroid and Hypertension
Chapter 137: Pregnancy and Hypertension
Chapter 138: Hypertension and Toxemia of Pregnancy
Chapter 139: CoQ10 and Arginine in Hypertension:Future Directions
Chapter 140: Role of Vitamin D Deficiency in Hypertension
Chapter 141: Understanding Chemotherapy and Radiation-induced Hypertension
Chapter 142: Resistant Hypertension with Heart Failure and Sepsis
Chapter 143: Resistant Hypertension with Heart Failure and ECMO
Chapter 144: Role of Yoga in Hypertension
Chapter 145: Exercise Training in Resistant Hypertension
Chapter 146: Review of Ongoing Drugs and Device Trials in Patient of Hypertension with HFpEF
Chapter 147: Review of Ongoing Trials with ARNI in Resistant Hypertension with Heart Failure
Chapter 148: Which Hypertension Guidelines should Indians Follow in 2020 and Beyond—AHA/ACC or ESC?
Chapter 149: Emerging Role of SGLT2 Inhibitors in Resistant Hypertension with Heart Failure